Literature DB >> 3500909

Interleukin 2 inhibits migration and stimulates respiratory burst and degranulation of human neutrophils in vitro.

I C Kowanko1, A Ferrante.   

Abstract

Interleukin 2 (IL2) is a lymphocyte product recognised for its role as a T lymphocyte growth factor. Since some other lymphokines and monokines can modulate the function of granulocytes we examined the effects of natural and recombinant human IL2 on neutrophil locomotion, respiratory burst and degranulation. Purified T cell-derived IL2 inhibited both random and chemotactically-directed migration of neutrophils. IL2 induced a respiratory burst and release of lysosomal enzymes in neutrophils and increased these responses in classically stimulated neutrophils. Recombinant IL2 was also effective in altering neutrophil functions. We conclude that IL2 modulates neutrophil function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500909     DOI: 10.1016/0165-2478(87)90129-5

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

1.  Neutrophil-mediated cartilage injury in vitro is enhanced by tumour necrosis factor alpha.

Authors:  I C Kowanko; E J Bates; A Ferrante
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  T cell-dependent chronic neutrophilia during mycobacterial infections.

Authors:  R Appelberg; M T Silva
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  Staphylococcus aureus-stimulated mononuclear leucocyte-conditioned medium increases the neutrophil bactericidal activity, and augments oxygen radical production and degranulation in response to the bacteria.

Authors:  A Ferrante; D P Harvey; E J Bates
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

4.  Dual mechanism in induction of human neutrophil cytotoxicity: activation of protein kinase C and elevation in intracellular calcium.

Authors:  R Gavioli; S Spisani; A L Giuliani; S Traniello
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

5.  Decreased luminol-dependent chemiluminescence response of neutrophils to recombinant human tumour necrosis factor in patients with gastric cancer.

Authors:  I A Schepetkin; N V Cherdyntseva; E V Borunov; I L Skutina; S A Naumov
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

6.  Tumour necrosis factor beta (lymphotoxin) inhibits locomotion and stimulates the respiratory burst and degranulation of neutrophils.

Authors:  A Ferrante; M Nandoskar; E J Bates; D H Goh; L J Beard
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

7.  Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release.

Authors:  A Ferrante
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

8.  Suppression of monocyte and neutrophil function by recombinant IL-2.

Authors:  S E Smith; G D Warren; Y H Thong; J G McCormack
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

9.  Pure Red Cell Aplasia Following Interleukin-2 Therapy.

Authors:  Janice P Dutcher; Wen Fan; Peter H Wiernik
Journal:  J Investig Med High Impact Case Rep       Date:  2016-04-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.